Skip to the content
  • 719-347-5400
  • [email protected]
Get Started for Free!
Log In
  • Research
    • Research Library
    • Participate
      • National Cannabis Study
      • Observational Research Registry
      • CBD for Aging Adults Research Study
  • Resources
    • Client Portal
      • Dosing & Administration
      • Client Education Series
      • Client F.A.Q.
        • Client Additional Questions
      • For Pets
      • Glossary
      • Locate a Healthcare Professional
      • Medical Cannabis Cards
      • Printable Resources
    • Healthcare Portal
      • Dosing & Administration
      • Join Our List of Healthcare Professionals
      • Practitioner Education
    • Events
      • Book Club
      • Virtual Support Groups
    • Partner Marketplace
    • Save Hemp 2026
    • Merch Shop
  • Blog
    • Education
    • Client Stories
  • About
    • Donate
    • Who We Are
    • In the News
    • Our Supporters
    • Financials
  • Contact Us
    • Call or Email
    • Request an Appointment
    • Volunteer
  • Research
    • Research Library
    • Participate
      • National Cannabis Study
      • Observational Research Registry
      • CBD for Aging Adults Research Study
  • Resources
    • Client Portal
      • Dosing & Administration
      • Client Education Series
      • Client F.A.Q.
        • Client Additional Questions
      • For Pets
      • Glossary
      • Locate a Healthcare Professional
      • Medical Cannabis Cards
      • Printable Resources
    • Healthcare Portal
      • Dosing & Administration
      • Join Our List of Healthcare Professionals
      • Practitioner Education
    • Events
      • Book Club
      • Virtual Support Groups
    • Partner Marketplace
    • Save Hemp 2026
    • Merch Shop
  • Blog
    • Education
    • Client Stories
  • About
    • Donate
    • Who We Are
    • In the News
    • Our Supporters
    • Financials
  • Contact Us
    • Call or Email
    • Request an Appointment
    • Volunteer
Log In
Donate
Log In
Donate
  • Research
    • Research Library
    • Participate
      • National Cannabis Study
      • Observational Research Registry
      • CBD for Aging Adults Research Study
  • Resources
    • Client Portal
      • Dosing & Administration
      • Client Education Series
      • Client F.A.Q.
        • Client Additional Questions
      • For Pets
      • Glossary
      • Locate a Healthcare Professional
      • Medical Cannabis Cards
      • Printable Resources
    • Healthcare Portal
      • Dosing & Administration
      • Join Our List of Healthcare Professionals
      • Practitioner Education
    • Events
      • Book Club
      • Virtual Support Groups
    • Partner Marketplace
    • Save Hemp 2026
    • Merch Shop
  • Blog
    • Education
    • Client Stories
  • About
    • Donate
    • Who We Are
    • In the News
    • Our Supporters
    • Financials
  • Contact Us
    • Call or Email
    • Request an Appointment
    • Volunteer
  • Research
    • Research Library
    • Participate
      • National Cannabis Study
      • Observational Research Registry
      • CBD for Aging Adults Research Study
  • Resources
    • Client Portal
      • Dosing & Administration
      • Client Education Series
      • Client F.A.Q.
        • Client Additional Questions
      • For Pets
      • Glossary
      • Locate a Healthcare Professional
      • Medical Cannabis Cards
      • Printable Resources
    • Healthcare Portal
      • Dosing & Administration
      • Join Our List of Healthcare Professionals
      • Practitioner Education
    • Events
      • Book Club
      • Virtual Support Groups
    • Partner Marketplace
    • Save Hemp 2026
    • Merch Shop
  • Blog
    • Education
    • Client Stories
  • About
    • Donate
    • Who We Are
    • In the News
    • Our Supporters
    • Financials
  • Contact Us
    • Call or Email
    • Request an Appointment
    • Volunteer

Research Library

A-Z Conditions  Participate in ORR

A within-subject cross-over trial comparing the acute effects of oral delta-8-tetrahydrocannabinol and delta-9-tetrahydrocannabinol in healthy adults

  • Journal : Drug and Alcohol Dependence
  • Publication Year : 2025
  • Authors : C. Austin Zamarripa, Tory R. Spindle, Destiny Schriefer, Edward J. Cone, Ruth E. Winecker, Ronald Flegel, Eugene Hayes, Lisa S. Davis, David Kuntz, Ryan Vandrey

Background: Oral products containing Δ8-tetrahydrocannabinol (Δ8-THC), a chemical isomer of the primary psychoactive consistent of cannabis, Δ9-tetrahydrocannabinol (Δ9-THC), have increased in popularity in recent years. The behavioral effects and pharmacokinetics of oral Δ8-THC remain poorly characterized. Methods: Nineteen healthy adults with no past-month cannabinoid exposure completed five randomized outpatient sessions in a within-subjects, double-blind, crossover design. Participants ingested a brownie containing Δ8-THC (10, 20, 40 mg), Δ9-THC (20 mg), or placebo. Measures included whole blood cannabinoid concentrations, subjective drug effects, cognitive/psychomotor performance, and vital signs. Results: Whole blood cannabinoid concentrations peaked between 2 and 4 h post-dose in a dose-orderly manner. The psychoactive 11-OH metabolite of Δ8-THC was markedly lower than that of Δ9-THC at the same dose. Δ8- THC produced dose-dependent subjective effects across multiple domains, differing from placebo. Compared to 20 mg Δ9-THC, 20 mg Δ8-THC resulted in significantly lower ratings of “feel drug effect,” negative subjective effects, cognitive/psychomotor impairment, and heart rate increases. No pharmacodynamic differences were observed between 40 mg Δ8-THC and 20 mg Δ9-THC. Both 20 mg and 40 mg Δ8-THC produced comparable positive subjective effects (e.g., drug liking) to 20 mg Δ9-THC, suggesting similar misuse potential. Conclusion: Δ8-THC demonstrated dose-dependent psychoactive effects qualitatively similar to Δ9-THC but with reduced potency, possibly due to lower biotransformation to its 11-OH metabolite. Importantly, higher doses of Δ8-THC offset reduced potency, as 40 mg Δ8-THC and 20 mg Δ9-THC produced similar effects; this is noteworthy considering people who consume cannabis products generally perceive Δ8-THC as less harmful or intoxicating than Δ9-THC. These findings inform regulatory decisions and public education, though further research on emergent cannabinoids is needed.

Read the Full Article

Share This:

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
PrevPreviousPrevalence of Gastrointestinal Adverse Events of Therapeutic Cannabinoids in Children: A Systematic Review and Meta-Analysis
NextCannabidiol (CBD): A Systematic Review of Clinical and Preclinical Evidence in the Treatment of PainNext

Conditions:

Research Information:

Research Keywords:

  • ∆9-tetrahydrocannabinol (THC), Cannabinoid/s

Search the Research Library >

Follow Us:

Facebook Twitter Youtube

REGISTER WITH RoC TODAY!

Realm of Caring focuses on research, education, building community, and improving quality of life. We are an educational resource for consumers, physicians, scientists, governments and the media.
Register now
  • PO Box 15224, Colorado Springs, CO 80935
  • 719-347-5400
  • [email protected]

Newsletter Sign-Up

Sign up to receive insights, news, and updates from Realm of Caring.

Email(Required)

Copyright © 2026 / Realm of Caring Foundation, Inc

  • Privacy
  • Disclaimer

Open the following in new tabs if you:

If you are already a user: Client Login

If you are not, then register: Client Registration

Once Logged in, click below to refresh the page.